—
We haven't found any bio for you yet.
Loading links...
Loading publications…
Scott M. Wilhelm, Lila Adnane, Philippa Newell, Augusto Villanueva, Josep M. Llovet, Mark Lynch (2008). Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Molecular Cancer Therapeutics, 7(10), pp. 3129-3140, DOI: 10.1158/1535-7163.mct-08-0013.
